These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36266627)

  • 1. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
    Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
    BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Xie HL; Liu T; Song MM; Ge YZ; Deng L; Shi HP
    Sci Rep; 2023 May; 13(1):7217. PubMed ID: 37137949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study.
    Chen X; Guo W; Diao Z; Huang H; Liu W
    Front Immunol; 2023; 14():1101222. PubMed ID: 36936907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study.
    Zhang KP; Zhang X; Zhang Q; Ruan GT; Song MM; Xie HL; Zhang HY; Li XR; Yang M; Liu YY; Li QQ; Ge YZ; Liu XY; Lin SQ; Li W; Xu HX; Deng L; Shi HP
    J Nutr Health Aging; 2022; 26(9):847-855. PubMed ID: 36156676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
    Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.
    Cheng CB; Zhang QX; Zhuang LP; Sun JW
    Jpn J Clin Oncol; 2020 Sep; 50(10):1141-1149. PubMed ID: 32564084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer?
    Angin YS; Yildirim M; Dasiran F; Okan I
    ANZ J Surg; 2021 Jul; 91(7-8):1521-1527. PubMed ID: 33956378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
    Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
    Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
    Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
    Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
    Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
    Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer.
    Miyatani K; Sawata S; Makinoya M; Miyauchi W; Shimizu S; Shishido Y; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Fujiwara Y
    BMC Cancer; 2022 Jun; 22(1):641. PubMed ID: 35690739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.
    Iseda N; Itoh S; Yoshizumi T; Tomiyama T; Morinaga A; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oda Y; Mori M
    Int J Clin Oncol; 2021 Oct; 26(10):1890-1900. PubMed ID: 34251555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
    Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
    Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
    Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
    J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients.
    Liu T; Liu C; Deng L; Song M; Lin S; Shi H
    Front Immunol; 2023; 14():1117232. PubMed ID: 36875131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-C-reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study.
    Lu LH; Zhong C; Wei W; Li SH; Mei J; Zou JW; Guo RP; Zhang YF
    Liver Int; 2021 Feb; 41(2):378-387. PubMed ID: 32562336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.